Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Other Accumulated Expenses (2016 - 2025)

CV Sciences' Other Accumulated Expenses history spans 10 years, with the latest figure at $1.5 million for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses changed N/A year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, changed N/A, while the annual FY2024 figure was $1.4 million, 5.89% down from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $1.5 million at CV Sciences, up from $1.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.5 million in Q4 2022 and bottomed at $1.4 million in Q1 2024.
  • The 4-year median for Other Accumulated Expenses is $1.5 million (2024), against an average of $1.5 million.
  • The largest annual shift saw Other Accumulated Expenses decreased 2.39% in 2023 before it dropped 5.89% in 2024.
  • A 4-year view of Other Accumulated Expenses shows it stood at $1.5 million in 2022, then fell by 2.39% to $1.5 million in 2023, then fell by 5.89% to $1.4 million in 2024, then grew by 5.62% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Other Accumulated Expenses are $1.5 million (Q3 2025), $1.4 million (Q4 2024), and $1.5 million (Q2 2024).